Effects of reapeated lung function tests - does an incentive improve the values?

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00026811

Enrollment

110

Registered

2022-01-13

Start date

2022-01-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Group 1: information that the person who improves their values the most wins 200 €. The study includes daily and weekly lung function tests including spirometry and bodyplethysmography. Group 2: contr

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: at least 18 years old, never smokers, no severe diseases especially not heart or lungs. no severe allergies. fully vaccinated against covid 19. normal lung function.

Exclusion criteria

Exclusion criteria: covid19 in the past, obstructive or restrictive ventilation patterns, pregnancy, breast feeding.

Design outcomes

Primary

Measure	Time frame
Collected via daily and weekly lung function tests (spirometry and bodyplethysmography) the vital capacity is the primary endpoint. The lung function tests are carried out for each volunteer over 12 weeks. With daily and weekly measurements a total of 22 values over the course of the study are collected.	—

Secondary

Measure	Time frame
Forced Expiratory Volume in 1 second	—

Countries

Germany

Contacts

Public ContactJulia Krabbe

Institut für Arbeits-, Sozial- und Umweltmedizin, Uniklinik RWTH Aachen

jkrabbe@ukaachen.de02418088881

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026